• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas驱动的单微电机(Cas-DSM)能够在单分子水平直接检测核酸生物标志物。

CRISPR-Cas-Driven Single Micromotor (Cas-DSM) Enables Direct Detection of Nucleic Acid Biomarkers at the Single-Molecule Level.

作者信息

Chen Desheng, Liang Yuanwen, Wang Honghong, Wang Hui, Su Fengxia, Zhang Pengbo, Wang Shuhui, Liu Weiliang, Li Zhengping

机构信息

Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, 30 Xueyuan Road, Haidian District, Beijing 100083, China.

出版信息

Anal Chem. 2023 Apr 4;95(13):5729-5737. doi: 10.1021/acs.analchem.2c05767. Epub 2023 Mar 21.

DOI:10.1021/acs.analchem.2c05767
PMID:36944919
Abstract

The target-dependent endonuclease activity (also known as the -cleavage activity) of CRISPR-Cas systems has stimulated great interest in the development of nascent sensing strategies for nucleic acid diagnostics. Despite many attempts, the majority of the sensitive CRISPR-Cas diagnostics strategies mainly rely on nucleic acid preamplification, which generally needs complex probes/primers designs, multiple experimental steps, and a longer testing time, as well as introducing the risk of false-positive results. In this work, we propose the CRISPR-Cas-Driven Single Micromotor (Cas-DSM), which can directly detect the nucleic acid targets at a single-molecule level with high specificity. We have demonstrated that the Cas-DSM is a reliable and practical method for the quantitative detection of DNA/RNA in various complex clinical samples as well as in individual cells without any preamplification processes. Due to the excellent features of the CRISPR/Cas system, including constant temperature, simple design, high specificity, and flexible programmability, the Cas-DSM could serve as a simple and universal platform for nucleic acid detection. More importantly, this work will provide a breakthrough for the development of next-generation amplification-free CRISPR/Cas sensing toolboxes.

摘要

CRISPR-Cas系统的靶标依赖性内切核酸酶活性(也称为切割活性)激发了人们对开发用于核酸诊断的新型传感策略的浓厚兴趣。尽管进行了许多尝试,但大多数灵敏的CRISPR-Cas诊断策略主要依赖于核酸预扩增,这通常需要复杂的探针/引物设计、多个实验步骤和更长的检测时间,还会引入假阳性结果的风险。在这项工作中,我们提出了CRISPR-Cas驱动的单微马达(Cas-DSM),它可以在单分子水平上以高特异性直接检测核酸靶标。我们已经证明,Cas-DSM是一种可靠且实用的方法,可用于在无需任何预扩增过程的情况下对各种复杂临床样本以及单个细胞中的DNA/RNA进行定量检测。由于CRISPR/Cas系统具有恒温、设计简单、特异性高和可编程性灵活等优异特性,Cas-DSM可作为一个简单通用的核酸检测平台。更重要的是,这项工作将为下一代无扩增CRISPR/Cas传感工具箱的开发提供突破。

相似文献

1
CRISPR-Cas-Driven Single Micromotor (Cas-DSM) Enables Direct Detection of Nucleic Acid Biomarkers at the Single-Molecule Level.CRISPR-Cas驱动的单微电机(Cas-DSM)能够在单分子水平直接检测核酸生物标志物。
Anal Chem. 2023 Apr 4;95(13):5729-5737. doi: 10.1021/acs.analchem.2c05767. Epub 2023 Mar 21.
2
CRISPR/Cas-Powered Amplification-Free Detection of Nucleic Acids: Current State of the Art, Challenges, and Futuristic Perspectives.CRISPR/Cas 驱动的无扩增核酸检测:当前的技术水平、挑战和未来展望。
ACS Sens. 2023 Dec 22;8(12):4420-4441. doi: 10.1021/acssensors.3c01463. Epub 2023 Nov 18.
3
An aM-level sensitive cascade CRISPR-Dx system (ASCas) for rapid detection of RNA without pre-amplification.一种用于快速检测RNA且无需预扩增的aM水平灵敏级联CRISPR-Dx系统(ASCas)。
Biosens Bioelectron. 2023 Jun 15;230:115248. doi: 10.1016/j.bios.2023.115248. Epub 2023 Mar 28.
4
Y-shaped DNA nanostructures assembled-spherical nucleic acids as target converters to activate CRISPR-Cas12a enabling sensitive ECL biosensing.Y 型 DNA 纳米结构组装的球形核酸作为靶标转换器,激活 CRISPR-Cas12a,实现灵敏的 ECL 生物传感。
Biosens Bioelectron. 2022 Oct 15;214:114512. doi: 10.1016/j.bios.2022.114512. Epub 2022 Jun 25.
5
Novel non-nucleic acid targets detection strategies based on CRISPR/Cas toolboxes: A review.基于 CRISPR/Cas 工具包的新型非核酸靶标检测策略:综述。
Biosens Bioelectron. 2022 Nov 1;215:114559. doi: 10.1016/j.bios.2022.114559. Epub 2022 Jul 13.
6
Next-Generation Diagnostic with CRISPR/Cas: Beyond Nucleic Acid Detection.基于 CRISPR/Cas 的下一代诊断技术:超越核酸检测。
Int J Mol Sci. 2022 May 27;23(11):6052. doi: 10.3390/ijms23116052.
7
Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System.基于 CRISPR-Cas 系统的生物传感器的多重检测策略。
ACS Synth Biol. 2024 Jun 21;13(6):1633-1646. doi: 10.1021/acssynbio.4c00161. Epub 2024 Jun 11.
8
Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.将 CRISPR-Cas12a 与基于 crRNA 的催化网络集成用于开发模块化和灵敏的适体传感器。
ACS Synth Biol. 2022 Aug 19;11(8):2829-2836. doi: 10.1021/acssynbio.2c00224. Epub 2022 Aug 10.
9
Cas12a/blocker DNA-based multiplex nucleic acid detection system for diagnosis of high-risk human papillomavirus infection.基于Cas12a/阻断剂DNA的多重核酸检测系统用于高危型人乳头瘤病毒感染的诊断
Biosens Bioelectron. 2023 Jul 15;232:115323. doi: 10.1016/j.bios.2023.115323. Epub 2023 Apr 14.
10
RNase H-Driven crRNA Switch Circuits for Rapid and Sensitive Detection of Various Analytical Targets.RNase H 驱动的 crRNA 开关电路,用于快速灵敏地检测各种分析物靶标。
Anal Chem. 2023 Dec 19;95(50):18549-18556. doi: 10.1021/acs.analchem.3c04267. Epub 2023 Dec 10.

引用本文的文献

1
Advanced Cancer Liquid Biopsy Platform for miRNA Detection in Extracellular Vesicles Using CRISPR/Cas13a and Gold Nanoarrays.用于使用CRISPR/Cas13a和金纳米阵列检测细胞外囊泡中miRNA的晚期癌症液体活检平台
ACS Nano. 2025 Jul 28. doi: 10.1021/acsnano.5c06940.
2
CRISPR detection of cardiac tumor-associated microRNAs.心脏肿瘤相关微小RNA的CRISPR检测
Mol Biol Rep. 2025 Jan 11;52(1):114. doi: 10.1007/s11033-024-10205-4.
3
CRISPR/Cas13a-Responsive and RNA-Bridged DNA Hydrogel Capillary Sensor for Point-of-Care Detection of RNA.
CRISPR/Cas13a 响应性和 RNA 桥接 DNA 水凝胶毛细管传感器,用于即时检测 RNA。
Anal Chem. 2024 Jul 23;96(29):12022-12029. doi: 10.1021/acs.analchem.4c02087. Epub 2024 Jul 13.
4
Rapid and Amplification-free Nucleic Acid Detection with DNA Substrate-Mediated Autocatalysis of CRISPR/Cas12a.基于DNA底物介导的CRISPR/Cas12a自催化实现快速免扩增核酸检测
ACS Omega. 2024 Jun 21;9(26):28866-28878. doi: 10.1021/acsomega.4c03413. eCollection 2024 Jul 2.